Riskpilot← Back to searchSign inGet full accessVita Reali AB
ABActiveOrg 5591949929Seglarängsvägen 27 BTraditional, complementary and alternative medicine activities · NACE 8696Est. 20191-4 employees
Revenue 2025
SEK 871K
-7% vs 2024
EBITDA margin
14.0%
+227% vs 2024
Equity ratio
45.9%
Financial strength
Net profit 2025
SEK 49K
+69% vs 2024
| Revenue | SEK 871K | -7% |
| EBITDA | SEK 122K | +227% |
| Net profit | SEK 49K | +69% |
| Total assets | SEK 625K | -4% |
| Equity | SEK 287K | +20% |
| Employees | — | — |
Legal name
Vita Reali AB
Org number
5591949929
Legal form
Aktiebolag
NACE code
8696 · Traditional, complementary and alternative medicine activities
Founded
14 februari 2019
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Vi erbjuder bl.a Fettfrysning, Body Toning, Cellulitreducering med Cryo Therapy & Insculpt samt Hälsoundersökningar, Naturläkare, Massage & Ansiktsbehandlingar. Försäljning av hälsokost och hudvårdsprodukter. Samt därmed förenlig verksamhet.
Address
Seglarängsvägen 27 B
Email
anna@annabille.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 486 | 1 376 | 1 052 | 940 | 871 |
| Staff expenses | — | −216 | −300 | −207 | −103 |
| EBITDA | −214 | 295 | 77 | 37 | 122 |
| Depreciation & amort. | −0 | −35 | −43 | −54 | −50 |
| EBIT | −214 | 260 | 33 | −17 | 72 |
| Net financials | — | −0 | −0 | 2 | 0 |
| Profit before tax | 596 | 168 | 24 | 38 | 61 |
| Tax | −0 | −32 | −3 | −9 | −13 |
| Net profit | 596 | 136 | 21 | 29 | 49 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 746 | 732 | 718 | 650 | 625 |
| Equity | 647 | 188 | 210 | 238 | 287 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 99 | 452 | 408 | 364 | 280 |
| Total debt | 99 | 452 | 408 | 364 | 280 |
EBITDA margin
14.0%
This company
15.8%
Market median
-11% vs market
20212025
Equity ratio
45.9%
This company
38.2%
Market median
+20% vs market
20212025
Return on equity
16.9%
This company
18.4%
Market median
+8% vs market
20212025
Net profit margin
5.6%
This company
8.1%
Market median
-31% vs market
20212025
Asset turnover
1.39×
This company
1.12×
Market median
+24% vs market
20212025
Debt / equity
1.18×
This company
0.62×
Market median
-90% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AS Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
| Former (2) | ||
| Deputy Board Member | 2020 – 2020 | |
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Vita Reali AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Sofia Bille | Chief Executive Officer | 0 companies |
| Berit Marie Axell | Deputy Board Member | 0 companies |
| Susanne Karin Kullenberg | Deputy Board Member | 0 companies |
| Jonas Peter Åke Kullenberg | Deputy Board Member | 0 companies |